ABSTRACT
Long-term prognosis of epilepsy was investigated on 117 institutionalized patients with severe motor and intellectual disabilities, who were above 15 years of age in 1977, for a 20-year-period from 1977 to 1997. The incidence of epilepsy was 64.1% (75 patients), which was active in 28 patients (37.3%). The patients with the most severe psychomotor disabilities (bedridden and DQ < 20) showed the highest incidence of epilepsy (85.0%). Patients who died during the follow-up period showed higher incidence of active epilepsy (p < 0.01). During the follow-up of 94 surviving patients, persistence, relapse, and onset of seizures were frequent in patients with most severe intellectual disability, whereas those with less severe intellectual disability (20 < DQ < 35) were all seizure-free. Twenty-one patients had active epilepsy; symptomatic partial epilepsy in 17 (81.0%) and generalized epilepsy in 4 (19.0%). Notably, 5 of the 6 patients with persistent frequent seizures had age-dependent epileptic encephalopathy; persistent Lennox-Gastaut syndrome (LGS) (2 patients), severe epilepsy with multiple independent spike foci evolved from West syndrome (WS) and LGS (2 patients), and partial epilepsy with the history of LGS (1 patient).
Subject(s)
Epilepsy/complications , Intellectual Disability/etiology , Psychomotor Disorders/etiology , Adolescent , Adult , Epilepsy/physiopathology , Epilepsy/psychology , Female , Follow-Up Studies , Humans , Male , PrognosisABSTRACT
The goal of this study is to clarify the prognostic factors in childhood localization-related epilepsy in a tertiary medical center. Children (n = 113) with symptomatic and cryptogenic localization-related epilepsy were divided into groups of intractable patients (average seizure frequency: one or more per month during the 6 months before the last follow-up; n = 40) and well-controlled patients (no seizures for at least 1 year before the last follow-up; n = 73). Clinical and electroencephalogram (EEG) factors were examined to elucidate prognostic factors. The subtypes of epilepsies and causes were also investigated. Univariate analyses indicated that the following factors were correlated with seizure outcome: (1) seizure type at the first visit; (2) seizure frequency; (3) underlying cause; (4) age at onset of epilepsy; (5) status epilepticus occurring as the first seizure and before the first visit; and (6) diffuse epileptic discharges on first visit interictal EEGs. Multivariate analyses revealed that seizure type at the first visit, seizure frequency, status epilepticus before the first visit, and underlying causes were significant independent predictive factors. The rate of intractable patients was highest in multilobar epilepsy, followed by frontal-lobe epilepsy. Regarding etiologies, the intractable group contained nine patients with encephalitis of unknown origin and three each with localized cortical malformation and mesial temporal sclerosis.
Subject(s)
Epilepsies, Partial/diagnosis , Epilepsies, Partial/etiology , Brain/abnormalities , Child , Child, Preschool , Electroencephalography , Encephalitis/complications , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging , Male , Prognosis , Sclerosis/complications , Sclerosis/pathology , Temporal Lobe/pathologyABSTRACT
The effect of lactation on the pharmacokinetics of phenobarbital (PB) after delivery was studied in female rats. Non-pregnant animals received PB 20 mg/kg/day twice for 6-7 days before mating, during pregnancy and after delivery. Chronic PB did not significantly influence changes in the body weight of rats after delivery. On the first post-delivery day, the plasma PB concentration in the PB-treated rats was significantly higher than that in PB-treated, non-pregnant rats (non-pregnant rats); and thereafter, it gradually decreased until ablactation on the 20th day. After ablactation, plasma PB concentrations gradually returned to the level before delivery. In PB-treated rats, pharmacokinetic parameters (Cmax, AUC0-12) of PB between 0 and 12 hr after a single oral administration were significantly decreased during lactation. These results suggest that PB administered during lactation is transferred in part to offspring through maternal milk.
Subject(s)
Anticonvulsants/blood , Lactation/blood , Phenobarbital/blood , Administration, Oral , Analysis of Variance , Animals , Anticonvulsants/administration & dosage , Anticonvulsants/pharmacokinetics , Anticonvulsants/pharmacology , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Female , Phenobarbital/administration & dosage , Phenobarbital/pharmacokinetics , Phenobarbital/pharmacology , Pregnancy , Rats , Rats, WistarSubject(s)
Anticonvulsants/pharmacokinetics , Epilepsy/blood , Valproic Acid/pharmacokinetics , Adolescent , Adult , Anticonvulsants/administration & dosage , Child , Child, Preschool , Delayed-Action Preparations , Dose-Response Relationship, Drug , Drug Administration Schedule , Epilepsy/drug therapy , Female , Humans , Male , Treatment Outcome , Valproic Acid/administration & dosageABSTRACT
A simple and rapid method for the quantitation of concentrations of lamotrigine, a novel antiepileptic, in human serum was developed with high-performance liquid chromatography, using a solid-phase extraction technique. The mobile phase was composed of acetonitrile-10 mM phosphate buffer (pH 3.5) containing 5 mM sodium octanesulphonate (27:73, v/v), and components were detected at 265 nm. Retention times of acetanilide as an internal standard and lamotrigine were 3.4 and 10.3 min, respectively. The coefficients of variation were 3.1-4.5% and 4.4-9.8% for the within-day and between-day precision estimates, respectively. The extraction recovery of lamotrigine added to blank serum was 86-107%. The quantitation limit of lamotrigine was ca. 0.2 microgram/ml in 100 microliters of serum. These results suggest that the method employed in this study is useful for the routine monitoring of serum concentrations of lamotrigine in epileptic patients.
Subject(s)
Anticonvulsants/blood , Triazines/blood , Anticonvulsants/pharmacokinetics , Biotransformation , Chromatography, High Pressure Liquid , Humans , Indicators and Reagents , Lamotrigine , Spectrophotometry, Ultraviolet , Triazines/pharmacokineticsSubject(s)
Anticonvulsants/therapeutic use , Valproic Acid/therapeutic use , Adolescent , Adult , Anticonvulsants/administration & dosage , Anticonvulsants/blood , Child , Child, Preschool , Delayed-Action Preparations , Female , Humans , Male , Solubility , Valproic Acid/administration & dosage , Valproic Acid/bloodABSTRACT
We investigated the etiology of West syndrome (WS) with special reference to prenatal factors in 180 cases. Prenatal cause was the most frequent diagnosis (77 cases, 42.8%), followed by perinatal (25 cases, 13.9%) and postnatal factors (12 cases, 6.7%); 48 cases (26.7%) were of uncertain etiology; eighteen cases (10.0%) were idiopathic. Of the three forms of age-dependent epileptic encephalopathy, prenatal cause was present in 12 of 15 cases (80.0%) of early-infantile epileptic encephalopathy with suppression-burst, 77 of 180 cases (42.8%) of WS, and 31 of 123 cases (25.2%) of Lennox-Gastaut syndrome (LGS). Prenatal factors of WS included tuberous sclerosis (23), chromosome abnormalities (10), cerebral dysgenesis (10), porencephaly (7), hydrocephalus (5), Aicardi syndrome (3), Aicardi syndrome associated with chromosome abnormality (1), and other causes (18). Chromosome abnormalities with WS consisted of 6 cases with 21 trisomy and one case each with 18q duplication, t(1;y) translocation, 7q duplication, and partial 2p trisomy. One patient with Aicardi syndrome also had a t(12;21) translocation. No significant difference was observed in the age of onset of WS among the five etiologic groups. The evolution from WS to LGS was not influenced by etiology, except for the idiopathic group. In patients followed for over 3 years, seizure remission occurred in 46.8% (22 of 47 cases) of the prenatal group. This was lower than the other four groups. Intellectual prognosis was also relatively poor in those with prenatal onset. Pyridoxal phosphate (PAL-P) treatment was effective in 9 of 70 (12.9%) prenatal cases and 5 of 18 (27.8%) idiopathic cases.(ABSTRACT TRUNCATED AT 250 WORDS)
Subject(s)
Pregnancy Complications , Spasms, Infantile/etiology , Abnormalities, Multiple/genetics , Brain/abnormalities , Chromosome Aberrations/genetics , Chromosome Disorders , Congenital Abnormalities/genetics , Electroencephalography , Epilepsy/complications , Female , Follow-Up Studies , Hemiplegia/complications , Humans , Hydrocephalus/complications , Infant , Infant, Newborn , Phenylketonurias/complications , Pregnancy , Pregnancy Complications/diagnosis , Prognosis , Pyridoxal Phosphate/therapeutic use , Spasms, Infantile/drug therapy , Spasms, Infantile/genetics , Syndrome , Trisomy , Tuberous Sclerosis/complicationsSubject(s)
Anticonvulsants/adverse effects , Epilepsies, Partial/drug therapy , Epilepsy, Generalized/drug therapy , Pregnancy Complications/drug therapy , Abnormalities, Drug-Induced/etiology , Adolescent , Anticonvulsants/therapeutic use , Child , Child, Preschool , Electroencephalography/drug effects , Epilepsies, Partial/genetics , Epilepsy, Generalized/genetics , Evoked Potentials, Auditory, Brain Stem/drug effects , Evoked Potentials, Auditory, Brain Stem/genetics , Evoked Potentials, Visual/drug effects , Evoked Potentials, Visual/genetics , Female , Follow-Up Studies , Humans , Infant , Infant, Newborn , Intellectual Disability/chemically induced , Intellectual Disability/genetics , Intelligence/drug effects , Intelligence/genetics , Male , Pregnancy , Prenatal Exposure Delayed Effects , Prospective Studies , Reaction Time/drug effects , Reaction Time/genetics , Risk FactorsSubject(s)
Electroencephalography , Epilepsies, Myoclonic/diagnosis , Adolescent , Child , Epilepsy, Absence/diagnosis , Evoked Potentials , Female , Follow-Up Studies , Humans , Intelligence , MaleSubject(s)
Anticonvulsants/adverse effects , Attention/drug effects , Electroencephalography/drug effects , Epilepsies, Partial/drug therapy , Epilepsy, Generalized/drug therapy , Evoked Potentials, Auditory/drug effects , Adolescent , Adult , Anticonvulsants/therapeutic use , Attention/physiology , Cerebral Cortex/drug effects , Cerebral Cortex/physiopathology , Child , Child, Preschool , Epilepsies, Partial/physiopathology , Epilepsy, Generalized/physiopathology , Evoked Potentials, Auditory/physiology , Female , Humans , Male , Reaction Time/drug effects , Reaction Time/physiologyABSTRACT
116 immunizations were given to 61 children with febrile convulsion or epilepsy who had not had a seizure for 1 year since the last attack. In 92 of the 116 immunizations the electroencephalogram (EEG) was examined before and after immunization. No adverse effects on the EEG were observed in 19 immunizations with Japanese encephalitis, measles, mumps or rubella vaccines. Epileptic spikes reappeared after 10 immunizations and epileptic spikes increased after 10 immunizations among 73 given for diphtheria, acellular pertussis and tetanus (DPT), diphtheria and tetanus (DT), or Bacillus Calmette-Guerin (BCG). A convulsion was observed once in one child 7 days after immunization with BCG. A follow-up EEG examination is necessary after children with convulsive disorders are immunized.
Subject(s)
Electroencephalography , Epilepsy/physiopathology , Seizures, Febrile/physiopathology , Vaccines/adverse effects , Adolescent , Child , Child, Preschool , Female , Humans , MaleSubject(s)
Epilepsies, Myoclonic/diagnosis , Spasms, Infantile/diagnosis , Child , Child, Preschool , Electroencephalography , Epilepsies, Myoclonic/genetics , Epilepsy, Temporal Lobe/diagnosis , Epilepsy, Tonic-Clonic/diagnosis , Evoked Potentials , Follow-Up Studies , Humans , Infant , Spasms, Infantile/genetics , SyndromeABSTRACT
Remarkable progress has been accomplished in epileptology in recent years. The remission rate in childhood epilepsy has been improved by the introduction of new technologies and better diagnostic as well as therapeutic methods. Investigation of prognosis is an important field of epileptology, because prognostic improvement reflects its overall progress. A long-term follow-up study of childhood epilepsy was undertaken in the Okayama University Hospital. Ten to 15 years of follow-up was possible in 730 of 1,295 patients who were first diagnosed at ages below 15 years, from 1968 to 1971. The 3-year remission rate amounted to 82.0% and 5-year remission was obtained in 79.1%. These high rates of remission indicate the favorable prognosis of childhood epilepsy. On the other hand, cases of intractable epilepsy also amounted to a considerable number. Intractable epilepsy consisted mainly of age-dependent epileptic encephalopathy (Ohtahara's syndrome, West syndrome and Lennox-Gastaut syndrome) and severe myoclonic epilepsy in infancy. Development of effective therapy for these intractable epileptic syndromes will be an important subject of future studies.
Subject(s)
Epilepsy/therapy , Adolescent , Child , Child, Preschool , Follow-Up Studies , Humans , Prognosis , Remission InductionABSTRACT
A multifaceted study on childhood refractory epilepsy disclosed an insufficient classification of epilepsies and epileptic seizures, and inappropriate polypharmacy as the most important factors preventing appropriate therapy. By means of an adjustment of AEDs based on the accurate classification of epilepsies and epileptic seizures, the number of AEDs could be reduced in 37.5% and monotherapy was successful in 13.8% of refractory cases. Most of the latter were those of partial epilepsy and generalized epilepsy with the monoseizure type. The exacerbation of seizures due to AEDs was also mentioned as one of the important side effects of AEDs.
Subject(s)
Anticonvulsants/therapeutic use , Epilepsy/drug therapy , Adolescent , Child , Child, Preschool , Drug Therapy, Combination , Epilepsies, Partial/drug therapy , Epilepsy/diagnosis , Epilepsy, Temporal Lobe/drug therapy , Female , Humans , Infant , Male , Spasms, Infantile/drug therapySubject(s)
Electroencephalography , Epilepsies, Myoclonic/physiopathology , Spasms, Infantile/physiopathology , Cerebral Cortex/physiopathology , Child, Preschool , Dominance, Cerebral/physiology , Epilepsies, Partial/physiopathology , Epilepsy, Temporal Lobe/physiopathology , Female , Follow-Up Studies , Humans , Infant , Male , Seizures, Febrile/physiopathologySubject(s)
Amino Acid Metabolism, Inborn Errors/metabolism , Brain Diseases, Metabolic/metabolism , Glycine/metabolism , Amino Acid Metabolism, Inborn Errors/physiopathology , Brain Diseases, Metabolic/physiopathology , Child, Preschool , Diazepam/therapeutic use , Electroencephalography , Follow-Up Studies , Humans , Infant , Infant, Newborn , Male , Myoclonus/drug therapy , Myoclonus/physiopathology , Pyridoxal Phosphate/therapeutic use , Spasms, Infantile/drug therapy , Spasms, Infantile/physiopathologySubject(s)
Adrenocorticotropic Hormone/therapeutic use , Epilepsy/drug therapy , Child , Child, Preschool , Female , Humans , Infant , Male , Spasms, Infantile/drug therapy , SyndromeSubject(s)
Spasms, Infantile/physiopathology , Adolescent , Age Factors , Brain/physiopathology , Child , Child, Preschool , Follow-Up Studies , Humans , Infant , Infant, Newborn , PrognosisABSTRACT
A clinico-electroencephalographic study on 14 cases of the early-infantile epileptic encephalopathy with suppression-burst (EIEE) including long-term follow-up studies for one year 8 months to 12 years 2 months disclosed the specificity of EIEE in its developmental aspects. With age, clinical evolution from EIEE to the West syndrome was observed in as many as 10 cases, among which two cases showed further transition to the Lennox-Gastaut syndrome. Electroencephalographically, suppression-burst pattern gradually began to disappear from age of 3 months and disappeared by 6 months in all the cases, transforming to hypsarhythmia in 10 cases from 2 to 6 months of age, showing further transition to diffuse slow spike-and-waves in 2 cases at one year and one month and at 3 years and one month of age, respectively. Changing pattern of EEG were classifiable into two types which strongly related to the prognosis. These findings indicated EIEE to be an independent epileptic syndrome as the earliest form of the age-dependent epileptic encephalopathy.